Promising Celiac Disease Drugs In The Pipeline
A number of drug manufacturers are currently conducting clinical trials to assess the safety and effectiveness of a number of novel drug agents. Each has a different approach and mechanism of action (MOA). It is hoped that by inhibiting a process of this disorder, we may one day entirely erase celiac disease from the lexicon of autoimmune illnesses. The most promising candidates in the drug pipeline include the following....